HEPATIC ERYTHROPOIETIN SYNTHESIS IS ENHANCED IN HEMODIALYSIS PATIENTS WHO DO NOT REQUIRE ERYTHROPOIESIS-STIMULATING AGENTS

被引：0
|
作者：
Hirayama, Aki [1 ]
Yanagawa, Takamoto [2 ]
Kaneko, Yoko [2 ]
Nagano, Yumiko [1 ]
Owada, Shigeru [3 ]
Ishizu, Takashi [2 ]
机构：
[1] Tsukuba Univ Technol, Ctr Integrar Med, Tsukuba, Ibaraki, Japan
[2] Tsukuba Cent Hosp, Dept Nephrol, Ushiku, Japan
[3] Asa Clin, Kawasaki, Kanagawa, Japan
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0847
引用
收藏
页码：1178 / 1178
页数：1
相关论文
共 50 条
  • [21] Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
    Aapro, M.
    Jelkmann, W.
    Constantinescu, S. N.
    Leyland-Jones, B.
    BRITISH JOURNAL OF CANCER, 2012, 106 (07) : 1249 - 1258
  • [22] BASAL HEMOGLOBIN PRODUCTION AND REQUIRED DOSE OF ERYTHROPOIESIS-STIMULATING AGENTS IN HEMODIALYSIS PATIENTS WITH ANEMIA
    Kuji, Tadashi
    Kaneda, Tomoko
    Nishihara, Masahiro
    Shibata, Kazuhiko
    Satta, Hidehisa
    Imoto, Kiyotaka
    Kawata, Sei-ichi
    Koguchi, Naoaki
    Fujikawa, Tetsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 463 - 463
  • [23] Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia
    Maruyama, Takashi
    Higuchi, Terumi
    Yamazaki, Toshio
    Okawa, Erina
    Ando, Hideyuki
    Oikawa, Osamu
    Inoshita, Atsushi
    Okada, Kazuyoshi
    Abe, Masanori
    CARDIORENAL MEDICINE, 2017, 7 (03) : 188 - 197
  • [24] Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients
    Gianni Biolo
    Gianfranco Guarnieri
    Rocco Barazzoni
    Giovanni Panzetta
    Clinical and Experimental Medicine, 2011, 11 : 181 - 187
  • [25] Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients
    Biolo, Gianni
    Guarnieri, Gianfranco
    Barazzoni, Rocco
    Panzetta, Giovanni
    CLINICAL AND EXPERIMENTAL MEDICINE, 2011, 11 (03) : 181 - 187
  • [26] Effects of Long-Term Erythropoiesis-Stimulating Agents on Iron Metabolism in Patients on Hemodialysis
    Onuma, Shoko
    Honda, Hirokazu
    Kobayashi, Yasuna
    Yamamoto, Toshinori
    Michihata, Tetsuo
    Shibagaki, Keigo
    Yuza, Toshitaka
    Hirao, Keiichi
    Tomosugi, Naohisa
    Shibata, Takanori
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (06) : 582 - 589
  • [27] Association of Serum Selenium Levels with the Response to Erythropoiesis-Stimulating Agents in Maintenance Hemodialysis Patients
    Yasukawa, Minoru
    Arai, Shigeyuki
    Nagura, Michito
    Hirohama, Daigoro
    Yamazaki, Osamu
    Tamura, Yoshifuru
    Fujigaki, Yoshihide
    Shibata, Shigeru
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 540 - 541
  • [28] Trends in use of erythropoiesis-stimulating agents and blood transfusions in US hemodialysis patients with cancer
    Butler, Anne M.
    Kshirsagar, Abhijit V.
    Olshan, Andrew F.
    Nielsen, Matthew E.
    Wheeler, Stephanie B.
    Brookhart, M. Alan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 141 - 142
  • [29] RESPONSIVENESS TO ERYTHROPOIESIS-STIMULATING AGENTS IN PREVALENT HEMODIALYSIS PATIENTS WITH CANCER; MULTICENTER SURVEILLANCE IN JAPAN
    Matsubara, Takeshi
    Kondo, Naoya
    Funakoshi, Taro
    Horimatsu, Takahiro
    Muto, Manabu
    Yanagita, Motoko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [30] Expression and function of erythropoietin receptors in tumors - Implications for the use of erythropoiesis-stimulating agents in cancer patients
    Sinclair, Angus M.
    Todd, Marque D.
    Forsythe, Kevin
    Knox, Susan J.
    Elliott, Steve
    Begley, C. Glenn
    CANCER, 2007, 110 (03) : 477 - 488
12345